FinTrust Capital Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-123
| Closed | -$909 | – | 1338 |
|
|
2023
Q2 | $909 | Hold |
123
| – | – | ﹤0.01% | 1102 |
|
|
2023
Q1 | $909 | Hold |
123
| – | – | ﹤0.01% | 1098 |
|
|
2022
Q4 | $909 | Hold |
123
| – | – | ﹤0.01% | 1100 |
|
|
2022
Q3 | $1K | Sell |
123
-498
| -80% | -$4.05K | ﹤0.01% | 1198 |
|
|
2022
Q2 | $7K | Hold |
621
| – | – | ﹤0.01% | 984 |
|
|
2022
Q1 | $7K | Sell |
621
-104,268
| -99% | -$1.18M | ﹤0.01% | 1020 |
|
|
2021
Q4 | $1.65M | Sell |
104,889
-1,093
| -1% | -$17.1K | 0.39% | 59 |
|
|
2021
Q3 | $1.82M | Buy |
105,982
+4,335
| +4% | +$74.3K | 0.48% | 50 |
|
|
2021
Q2 | $2.19M | Buy |
+101,647
| New | +$2.19M | 0.57% | 43 |
|
|
2019
Q1 | – | Sell |
-1,000
| Closed | -$26K | – | 1338 |
|
|
2018
Q4 | $26K | Buy |
+1,000
| New | +$26K | 0.01% | 528 |
|